Key statistics
On Friday, Syndax Pharmaceuticals Inc (SNDX:NSQ) closed at 21.81, -13.93% below its 52-week high of 25.34, set on Feb 28, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 21.54 |
---|---|
High | 22.02 |
Low | 21.31 |
Bid | 21.85 |
Offer | 22.10 |
Previous close | 21.52 |
Average volume | 1.19m |
---|---|
Shares outstanding | 85.36m |
Free float | 83.79m |
P/E (TTM) | -- |
Market cap | 1.86bn USD |
EPS (TTM) | -3.63 USD |
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
- Foundation Medicine Partners with Syndax to Develop a Companion Diagnostic in Hematology and Support Efforts to Pursue Regulatory Approval for an Assay Based on the FoundationOne®Heme Platform
- Incyte and Syndax Announce U.S. FDA Approval of Niktimvo™ (axatilimab-csfr) for the Treatment of Chronic Graft-Versus-Host Disease (GVHD)